These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3327482)
1. Correlations between titres from direct immunofluorescence and bioassay for assessment of potency of "Celvivac" swine fever live vaccine. Popa M; Barnaure G; Movanu R; Motroc P Arch Exp Veterinarmed; 1987 Nov; 41(6):836-40. PubMed ID: 3327482 [No Abstract] [Full Text] [Related]
2. [Control of European (classical) hog cholera]. Neukirch M Tierarztl Prax; 1980; 8(1):55-74. PubMed ID: 6758195 [No Abstract] [Full Text] [Related]
3. A micromethod for measuring swine fever antibody by neutralisation and immunofluorescence. Loi JS; Lim GH; Chu KT; NG MK Res Vet Sci; 1986 May; 40(3):408-10. PubMed ID: 3526486 [TBL] [Abstract][Full Text] [Related]
4. Development of maternal antibodies after oral vaccination of young female wild boar against classical swine fever. Kaden V; Lange E Vet Microbiol; 2004 Oct; 103(1-2):115-9. PubMed ID: 15381274 [TBL] [Abstract][Full Text] [Related]
6. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859 [TBL] [Abstract][Full Text] [Related]
7. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Rau H; Revets H; Balmelli C; McCullough KC; Summerfield A Vet Res; 2006; 37(1):155-68. PubMed ID: 16336932 [TBL] [Abstract][Full Text] [Related]
8. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model. Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136 [TBL] [Abstract][Full Text] [Related]
10. Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes. Suter R; Summerfield A; Thomann-Harwood LJ; McCullough KC; Tratschin JD; Ruggli N Vaccine; 2011 Feb; 29(7):1491-503. PubMed ID: 21184857 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus. Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794 [TBL] [Abstract][Full Text] [Related]
13. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Suradhat S; Kesdangsakonwut S; Sada W; Buranapraditkun S; Wongsawang S; Thanawongnuwech R Vaccine; 2006 Mar; 24(14):2634-42. PubMed ID: 16406169 [TBL] [Abstract][Full Text] [Related]
14. Porcine interleukin-3 enhances DNA vaccination against classical swine fever. Andrew M; Morris K; Coupar B; Sproat K; Oke P; Bruce M; Broadway M; Morrissy C; Strom D Vaccine; 2006 Apr; 24(16):3241-7. PubMed ID: 16457910 [TBL] [Abstract][Full Text] [Related]
16. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Li N; Qiu HJ; Zhao JJ; Li Y; Wang MJ; Lu BW; Han CG; Hou Q; Wang ZH; Gao H; Peng WP; Li GX; Zhu QH; Tong GZ Vaccine; 2007 Apr; 25(15):2907-12. PubMed ID: 17007970 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of lyophilised C-strain vaccine after oral immunisation of domestic pigs and wild boar against classical swine fever: first results. Faust A; Lange E; Kaden V Dtsch Tierarztl Wochenschr; 2007 Nov; 114(11):412-7. PubMed ID: 18077931 [TBL] [Abstract][Full Text] [Related]
18. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus. Dong XN; Chen YH Vaccine; 2006 May; 24(19):4029-34. PubMed ID: 16504346 [TBL] [Abstract][Full Text] [Related]
19. Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes. Monsó M; Tarradas J; de la Torre BG; Sobrino F; Ganges L; Andreu D J Pept Sci; 2011 Jan; 17(1):24-31. PubMed ID: 20812373 [TBL] [Abstract][Full Text] [Related]